Breaking News Instant updates and real-time market news.

2020-11-30 11:23:11 HXGBY Hexagon AB $0.00 / + (+0.00%) 11:23 11/30/20 11/30 11:23 11/30/20 11:23	Hexagon AB price target raised to SEK 640 from SEK 540 at Deutsche Bank Deutsche Bank analyst Alex Tout raised the firm's price target on Hexagon AB to SEK 640 from SEK 540 and keeps a Hold rating on the shares.
HXGBY Hexagon AB $0.00 / + (+0.00%) 10/29/20 JPMorgan Hexagon AB price target raised to SEK 640 from SEK 540 at JPMorgan 10/29/20 Morgan Stanley Hexagon AB price target raised to SEK 540 from SEK 520 at Morgan Stanley 10/29/20 Barclays Hexagon AB price target raised to SEK 530 from SEK 440 at Barclays 09/01/20 DNB Markets Hexagon AB upgraded to Buy from Hold at DNB Markets

2020-11-30 11:23:11

HXGBY

Hexagon AB

$0.00 / + (+0.00%)

11:23

11/30/20

11/30

11:23

11/30/20

11:23

Hexagon AB price target raised to SEK 640 from SEK 540 at Deutsche Bank

Deutsche Bank analyst Alex Tout raised the firm's price target on Hexagon AB to SEK 640 from SEK 540 and keeps a Hold rating on the shares.

HXGBY Hexagon AB

$0.00 / + (+0.00%)

10/29/20 JPMorgan: Hexagon AB price target raised to SEK 640 from SEK 540 at JPMorgan

10/29/20 Morgan Stanley: Hexagon AB price target raised to SEK 540 from SEK 520 at Morgan Stanley

10/29/20 Barclays: Hexagon AB price target raised to SEK 530 from SEK 440 at Barclays

09/01/20 DNB Markets: Hexagon AB upgraded to Buy from Hold at DNB Markets

TODAY'S FREE FLY STORIES

Hot Stocks	Biden announces plans for U.S. to buy 200M extra COVID-19 doses » 17:41 01/26/21 01/26 17:41 01/26/21 17:41 PFE Pfizer $37.31 / +0.025 (+0.07%) , BNTX BioNTech $106.18 / -4.355 (-3.94%) , MRNA Moderna $151.85 / +4.85 (+3.30%) , SPX S&P 500 $0.00 / + (+0.00%) , SPY SPDR S&P 500 ETF Trust $383.82 / -0.58 (-0.15%) U.S. President Joe Biden… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options Technical Analysis PFE BNTX MRNA SPX SPY PFE Pfizer $37.31 / +0.025 (+0.07%) 06:56 Today Myovant Sciences, Pfizer report 'positive' results from Phase 3 SPIRIT study 01/25/21 Minnesota DOH reports first U.S. case of COVID-19 variant first found in Brazil 01/25/21 Pfizer, Merck KGaA announce EC approval of Bavencio for UC patients 01/22/21 Pfizer, BioNTech reach agreement with COVAX for advance purchase of vaccine BNTX BioNTech $106.18 / -4.355 (-3.94%) 01/25/21 Minnesota DOH reports first U.S. case of COVID-19 variant first found in Brazil 01/25/21 BioNTech, Shanghai Fosun receive Hong Kong approval for Covid vaccine 01/22/21 Pfizer, BioNTech reach agreement with COVAX for advance purchase of vaccine 01/20/21 Pfizer, BioNTech: COVID-19 vaccine elicits antibodies neutralizing pseudovirus MRNA Moderna $151.85 / +4.85 (+3.30%) 08:08 Today Moderna provides U.S. supply update for COVID-19 vaccine 01/25/21 Minnesota DOH reports first U.S. case of COVID-19 variant first found in Brazil 01/25/21 Moderna announces results from COVID-19 Vaccine study against new strains 01/21/21 Moderna announces 1st participant dosed in Japan study of Moderna COVID vaccine SPX S&P 500 $0.00 / + (+0.00%) 01/25/21 Minnesota DOH reports first U.S. case of COVID-19 variant first found in Brazil 01/11/21 Gundlach recommends owning emerging markets with deflation hedges 01/11/21 Gundlach says emerging markets in Asia is best equity trade 01/11/21 Gundlach sees inflation rise in May, June being 'massive game-changer' SPY SPDR S&P 500 ETF Trust $383.82 / -0.58 (-0.15%) 01/25/21 Minnesota DOH reports first U.S. case of COVID-19 variant first found in Brazil 01/11/21 Gundlach recommends owning emerging markets with deflation hedges 01/11/21 Gundlach says emerging markets in Asia is best equity trade 01/11/21 Gundlach sees inflation rise in May, June being 'massive game-changer' PFE BNTX MRNA SPX SPY PFE Pfizer $37.31 / +0.025 (+0.07%) 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 01/14/21 Oppenheimer Essa Pharma price target raised to $20 from $9 at Oppenheimer 01/05/21 Argus Viatris initiated with a Hold at Argus 12/31/20 Ladenburg UK study supports potential of Arcturus COVID vaccine candidate, says Ladenburg BNTX BioNTech $106.18 / -4.355 (-3.94%) 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 12/29/20 Citi Arcturus selloff brings 'very good' buying opportunity, says Citi 12/22/20 Roth Capital Translate Bio price target raised to $37 from $30 at Roth Capital 12/15/20 Jefferies Jefferies starts Maravai at Buy, says 'more than just a COVID vaccine play' MRNA Moderna $151.85 / +4.85 (+3.30%) 01/25/21 Piper Sandler Piper reiterates $170 target on Moderna with vaccine active on new strains 01/14/21 Morgan Stanley 80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley 01/06/21 Piper Sandler Moderna price target raised to $170 after EU vaccine approval at Piper Sandler 01/04/21 Piper Sandler Moderna shares warrant 'fresh look' after 41% pullback, says Piper Sandler SPX S&P 500 $0.00 / + (+0.00%) 01/07/21 Credit Suisse Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside 11/09/20 JPMorgan JPMorgan sees S&P 500 hitting 4,000 by early next year 09/01/20 Fed's Brainard says monetary policy to pivot from stabilization to accommodation 08/17/20 Goldman Sachs Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000 SPY SPDR S&P 500 ETF Trust $383.82 / -0.58 (-0.15%) 01/07/21 Credit Suisse Credit Suisse raises 2021 S&P 500 target to 4,200, sees 12% upside 11/09/20 JPMorgan JPMorgan sees S&P 500 hitting 4,000 by early next year 09/01/20 Fed's Brainard says monetary policy to pivot from stabilization to accommodation 08/17/20 Goldman Sachs Goldman boosts end of 2020 S&P 500 target to 3,600 from 3,000 PFE BNTX MRNA PFE Pfizer $37.31 / +0.025 (+0.07%) 01/12/21 Pfizer sees FY21 EPS around $3.00-$3.10, consensus $3.07 10/27/20 Pfizer sees FY20 Upjohn revenue $8B-$8.5B, adjusted EBITDA $3.8B-$4.2B 10/27/20 Pfizer sees FY20 adjusted EPS for New Pfizer $2.28-$2.38, revenue $40.8B-$42.4B 10/27/20 Pfizer narrows FY20 adjusted EPS view to $2.88-$2.93 from $2.85-$2.95 BNTX BioNTech $106.18 / -4.355 (-3.94%) 08/11/20 BioNTech reports Q2 EPS (EUR38c), consensus (EUR24c) 07/31/20 Pfizer, BioNTech to supply Japan with 120M doses of BNT162 vaccine candidate MRNA Moderna $151.85 / +4.85 (+3.30%) 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) 10/28/20 Notable companies reporting before tomorrow's open 10/28/20 Notable companies reporting before tomorrow's open 08/05/20 Moderna reports Q2 EPS (31c), consensus (35c) 23 Jul 19 May 12 Feb 06 Feb PFE BNTX MRNA SPX SPY PFE Pfizer $37.31 / +0.025 (+0.07%) 09:37 Today Pfizer sees ability to deliver vaccine faster than expected, Bloomberg reports 01/25/21 Italy issues warning letter to Pfizer due to COVID vaccine delays, Reuters says 01/25/21 Pfizer to ship fewer vaccine vials to fulfill commitment to U.S., NY Times says 01/21/21 Pfizer slashes vaccine deliveries to some EU countries by 50%, Reuters reports BNTX BioNTech $106.18 / -4.355 (-3.94%) 09:37 Today Pfizer sees ability to deliver vaccine faster than expected, Bloomberg reports 01/21/21 Pfizer slashes vaccine deliveries to some EU countries by 50%, Reuters reports 01/21/21 Pfizer and BioNTech agree to supply vaccine to WHO co-led effort, Reuters says 01/20/21 Hong Kong set to approve COVID vaccine by Pfizer/BioNTech, SCMP says MRNA Moderna $151.85 / +4.85 (+3.30%) 01/20/21 McKesson to replace some Moderna vaccine shots shipped too cold, Bloomberg says 01/14/21 Moderna plans to test COVID-19 Vaccine booster shot, CNBC says 01/13/21 Moderna CEO says COVID-19 will be around 'forever,' CNBC says 01/11/21 EU close to 200M dose deal with Novavax, Moderna talks ongoing, Reuters reports SPX S&P 500 $0.00 / + (+0.00%) 15:33 Today Schumer says Senate Dems may proceed on COVID aid without GOP, Reuters says 14:03 Today Democrats introduce bill to raise federal minimum wage to $15 an hour, CNBC says 12:44 Today Britain exceeds 100,000 total COVID-19 deaths, Reuters reports 01/25/21 Janet Yellen confirmed as U.S. Treasury Secretary, NY Times reports SPY SPDR S&P 500 ETF Trust $383.82 / -0.58 (-0.15%) 15:33 Today Schumer says Senate Dems may proceed on COVID aid without GOP, Reuters says 14:03 Today Democrats introduce bill to raise federal minimum wage to $15 an hour, CNBC says 12:44 Today Britain exceeds 100,000 total COVID-19 deaths, Reuters reports 01/25/21 Janet Yellen confirmed as U.S. Treasury Secretary, NY Times reports PFE BNTX MRNA PFE Pfizer $37.31 / +0.025 (+0.07%) 01/25/21 Fly Intel: Wall Street's top stories for Monday 01/25/21 Fly Intel: Wall Street's top stories at midday 01/12/21 Fly Intel: Wall Street's top stories for Tuesday 01/12/21 Fly Intel: Wall Street's top stories at midday BNTX BioNTech $106.18 / -4.355 (-3.94%) 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 01/05/21 Fly Intel: Wall Street's top stories for Tuesday 01/05/21 Fly Intel: Wall Street's top stories at midday MRNA Moderna $151.85 / +4.85 (+3.30%) 01/25/21 Fly Intel: Wall Street's top stories for Monday 01/25/21 Fly Intel: Wall Street's top stories at midday 01/19/21 Fly Intel: Wall Street's top stories for Tuesday 01/14/21 Fly Intel: Wall Street's top stories for Thursday 02/08/21 17th Annual Virtual WORLDSymposium 2021 03/01/21 41st Annual Healthcare Virtual Conference 03/02/21 2021 London Global Healthcare Virtual Conference 02/02/21 Pfizer - PFE 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 PFE BNTX MRNA SPX SPY PFE Pfizer $37.31 / +0.025 (+0.07%) 01/25/21 Pfizer call volume above normal and directionally bullish 12/15/20 Notable open interest changes for December 15th 12/14/20 Unusually active option classes on open December 14th 12/11/20 Unusually active option classes on open December 11th BNTX BioNTech $106.18 / -4.355 (-3.94%) 14:35 Today BioNTech SE put volume heavy and directionally bearish 01/19/21 Largest borrow rate increases among liquid names 11/23/20 Largest borrow rate increases among liquid names 11/20/20 Unusually active option classes on open November 20th MRNA Moderna $151.85 / +4.85 (+3.30%) 01/25/21 Moderna call volume above normal and directionally bullish 12/17/20 Moderna call volume above normal and directionally bullish 11/27/20 Moderna call buyer realizes 22% same-day gains 11/25/20 Moderna call volume above normal and directionally bullish SPX S&P 500 $0.00 / + (+0.00%) 09:18 Today Overnight activity included 1053 trades in SPX and 29 trades in VIX 01/25/21 Overnight activity included 1215 trades in SPX and 15 trades in VIX 01/22/21 Overnight activity included 1489 trades in SPX and 44 trades in VIX 01/21/21 Overnight activity included 803 trades in SPX and 14 trades in VIX SPY SPDR S&P 500 ETF Trust $383.82 / -0.58 (-0.15%) 11/09/20 Options markets on track for record option volume SPX SPY SPX S&P 500 $0.00 / + (+0.00%) 01/22/21 On The Fly: Weekly technical notes for S&P 500 01/15/21 On The Fly: Weekly technical notes for S&P 500 01/08/21 On The Fly: Weekly technical notes for S&P 500 12/31/20 On The Fly: Weekly technical notes for S&P 500 SPY SPDR S&P 500 ETF Trust $383.82 / -0.58 (-0.15%) 08:21 Today SPDR S&P 500 ETF Trust: Pivot points 01/25/21 SPDR S&P 500 ETF Trust: Pivot points 01/22/21 On The Fly: Weekly technical notes for S&P 500 01/22/21 SPDR S&P 500 ETF Trust: Pivot points
Hot Stocks	Synchrony announces approval of $1.6B share repurchase program » 17:38 01/26/21 01/26 17:38 01/26/21 17:38 SYF Synchrony $35.37 / -1.26 (-3.44%) Synchrony Financial… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options SYF Synchrony $35.37 / -1.26 (-3.44%) 11:01 Today Synchrony to acquire Allergro Credit; financial terms not disclosed 01/21/21 Synchrony, Mattress Firm renew consumer financing strategic partnership 01/13/21 Walgreens expands financial services in pact with Synchrony, Mastercard 01/12/21 Synchrony names Brian Doubles as CEO, succeeding Margaret Keane SYF Synchrony $35.37 / -1.26 (-3.44%) 06:35 Today JMP Securities Synchrony price target raised to $43 from $36 at JMP Securities 01/19/21 JPMorgan Synchrony upgraded to Overweight with $46 target at JPMorgan 01/19/21 JPMorgan Synchrony upgraded to Overweight from Neutral at JPMorgan 01/06/21 Deutsche Bank Synchrony price target raised to $51 from $31 at Deutsche Bank SYF Synchrony $35.37 / -1.26 (-3.44%) 11/02/20 Fly Intel: What to watch in PayPal earnings report 10/20/20 Synchrony reports Q3 EPS 52c, consensus 70c SYF Synchrony $35.37 / -1.26 (-3.44%) 11/30/20 Apple upgrade, Slack downgrade among today's top calls on Wall Street 10/20/20 Fly Intel: Wall Street's top stories for Tuesday 10/20/20 Fly Intel: Wall Street's top stories at midday 10/20/20 Fly Intel: Pre-market Movers 01/29/21 Synchrony - SYF SYF Synchrony $35.37 / -1.26 (-3.44%) 10/08/20 Synchrony call volume above normal and directionally bullish 09/09/20 Synchrony call volume above normal and directionally bullish 09/04/20 Early notable gainers among liquid option names on September 4th 09/02/20 Synchrony put volume heavy and directionally bearish
Hot Stocks	Starbucks continues to see volatility in China 17:38 01/26/21 01/26 17:38 01/26/21 17:38 SBUX Starbucks $104.69 / +1.34 (+1.30%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SBUX Starbucks $104.69 / +1.34 (+1.30%) 17:37 Today Starbucks 'delighted' with pace of business recovery in Q1 17:30 Today Starbucks COO Roz Brewer to step down 17:20 Today Starbucks says food service continues to be soft 17:19 Today Starbucks entered 15 new cities in China in Q1 SBUX Starbucks $104.69 / +1.34 (+1.30%) 01/21/21 MKM Partners Starbucks' Q1 may show slowdown in U.S. comp trends, says MKM Partners 01/19/21 Goldman Sachs Starbucks initiated with a Buy at Goldman Sachs 01/14/21 Cleveland Research Cleveland Research lowers Starbucks Q1 Americas comps forecast 12/16/20 Stephens Starbucks pointed to softer U.S., stronger China than expected, says Stephens SBUX Starbucks $104.69 / +1.34 (+1.30%) 17:36 Today Starbucks sees January U.S. SSS down 2% 16:59 Today Starbucks backs FY21 revenue view of $28.0B-$29.0B, consensus $28.5B 16:08 Today Starbucks backs FY21 EPS $2.70-$2.90, consensus $2.81 16:07 Today Starbucks sees Q2 EPS 45c-50c, consensus 59c SBUX Starbucks $104.69 / +1.34 (+1.30%) 12/12/20 Starbucks, Disney can still offer investors growth, Barron's says 11/18/20 Starbucks to raise wages for baristas, CNBC reports 10/15/20 Starbucks to tie executive pay to diversity targets, WSJ reports 08/29/20 Starbucks stock getting a post-COVID jolt, Barron's says SBUX Starbucks $104.69 / +1.34 (+1.30%) 12/16/20 Fly Intel: Wall Street's top stories for Wednesday 12/16/20 Fly Intel: Wall Street's top stories at midday 12/10/20 Fly Intel: Wall Street's top stories for Thursday 12/10/20 Fly Intel: Wall Street's top stories at midday 17:00 Today Starbucks - SBUX 03/17/21 Starbucks Corporation SBUX Starbucks $104.69 / +1.34 (+1.30%) 15:19 Today Starbucks options imply 6.1% move in share price post-earnings 12/10/20 Early notable gainers among liquid option names on December 10th 11/17/20 Unusual call flow in option market yesterday 11/16/20 Short-term Starbucks calls see latte early flow
Syndicate	Duck Creek Technologies files to sell 8M shares of common stock » 17:38 01/26/21 01/26 17:38 01/26/21 17:38 DCT Duck Creek Technologies $52.81 / +0.84 (+1.62%) Duck Creek Technologies… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options DCT Duck Creek Technologies $52.81 / +0.84 (+1.62%) 01/12/21 Builders Mutual Insurance selects Duck Creek Suite OnDemand DCT Duck Creek Technologies $52.81 / +0.84 (+1.62%) 01/13/21 Goldman Sachs Sapiens initiated with a Neutral at Goldman Sachs 10/21/20 RBC Capital Duck Creek Technologies price target raised to $51 from $45 at RBC Capital 10/21/20 Barclays Duck Creek Technologies price target raised to $48 from $43 at Barclays 09/08/20 DA Davidson Duck Creek Technologies initiated with a Buy at DA Davidson DCT Duck Creek Technologies $52.81 / +0.84 (+1.62%) 01/07/21 Duck Creek Technologies sees FY21 revenue $246M-$251M, consensus $246.91M 01/07/21 Duck Creek Technologies sees Q2 revenue $58.5M-$59.5M, consensus $58.73M 01/07/21 Duck Creek Technologies reports Q1 EPS 2c, consensus (1c) 10/20/20 Duck Creek Technologies sees FY21 EPS (4c) -(2c), consensus (10c) 11 Nov 14 Aug DCT Duck Creek Technologies $52.81 / +0.84 (+1.62%) 11/01/20 Opening Day: MediaAlpha jumps 64%, Root falls flat in debut 08/16/20 Opening Day: COVID vaccine researcher surges following IPO 02/11/21 Technology & Internet Virtual Conference DCT Duck Creek Technologies $52.81 / +0.84 (+1.62%) 01/07/21 Duck Creek Technologies options imply 10.1% move in share price post-earnings 09/02/20 Seven new option listings and two option delistings on September 2nd
Hot Stocks	Starbucks 'delighted' with pace of business recovery in Q1 » 17:37 01/26/21 01/26 17:37 01/26/21 17:37 SBUX Starbucks $104.69 / +1.34 (+1.30%) Says U.S. business on… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SBUX Starbucks $104.69 / +1.34 (+1.30%) 17:30 Today Starbucks COO Roz Brewer to step down 17:20 Today Starbucks says food service continues to be soft 17:19 Today Starbucks entered 15 new cities in China in Q1 17:14 Today Starbucks says mobile orders now make up 25% of all transactions SBUX Starbucks $104.69 / +1.34 (+1.30%) 01/21/21 MKM Partners Starbucks' Q1 may show slowdown in U.S. comp trends, says MKM Partners 01/19/21 Goldman Sachs Starbucks initiated with a Buy at Goldman Sachs 01/14/21 Cleveland Research Cleveland Research lowers Starbucks Q1 Americas comps forecast 12/16/20 Stephens Starbucks pointed to softer U.S., stronger China than expected, says Stephens SBUX Starbucks $104.69 / +1.34 (+1.30%) 17:36 Today Starbucks sees January U.S. SSS down 2% 16:59 Today Starbucks backs FY21 revenue view of $28.0B-$29.0B, consensus $28.5B 16:08 Today Starbucks backs FY21 EPS $2.70-$2.90, consensus $2.81 16:07 Today Starbucks sees Q2 EPS 45c-50c, consensus 59c SBUX Starbucks $104.69 / +1.34 (+1.30%) 12/12/20 Starbucks, Disney can still offer investors growth, Barron's says 11/18/20 Starbucks to raise wages for baristas, CNBC reports 10/15/20 Starbucks to tie executive pay to diversity targets, WSJ reports 08/29/20 Starbucks stock getting a post-COVID jolt, Barron's says SBUX Starbucks $104.69 / +1.34 (+1.30%) 12/16/20 Fly Intel: Wall Street's top stories for Wednesday 12/16/20 Fly Intel: Wall Street's top stories at midday 12/10/20 Fly Intel: Wall Street's top stories for Thursday 12/10/20 Fly Intel: Wall Street's top stories at midday 17:00 Today Starbucks - SBUX 03/17/21 Starbucks Corporation SBUX Starbucks $104.69 / +1.34 (+1.30%) 15:19 Today Starbucks options imply 6.1% move in share price post-earnings 12/10/20 Early notable gainers among liquid option names on December 10th 11/17/20 Unusual call flow in option market yesterday 11/16/20 Short-term Starbucks calls see latte early flow

Earnings	Starbucks sees January U.S. SSS down 2% » 17:36 01/26/21 01/26 17:36 01/26/21 17:36 SBUX Starbucks $104.69 / +1.34 (+1.30%) Sees total January SSS… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SBUX Starbucks $104.69 / +1.34 (+1.30%) 17:30 Today Starbucks COO Roz Brewer to step down 17:20 Today Starbucks says food service continues to be soft 17:19 Today Starbucks entered 15 new cities in China in Q1 17:14 Today Starbucks says mobile orders now make up 25% of all transactions SBUX Starbucks $104.69 / +1.34 (+1.30%) 01/21/21 MKM Partners Starbucks' Q1 may show slowdown in U.S. comp trends, says MKM Partners 01/19/21 Goldman Sachs Starbucks initiated with a Buy at Goldman Sachs 01/14/21 Cleveland Research Cleveland Research lowers Starbucks Q1 Americas comps forecast 12/16/20 Stephens Starbucks pointed to softer U.S., stronger China than expected, says Stephens SBUX Starbucks $104.69 / +1.34 (+1.30%) 16:59 Today Starbucks backs FY21 revenue view of $28.0B-$29.0B, consensus $28.5B 16:08 Today Starbucks backs FY21 EPS $2.70-$2.90, consensus $2.81 16:07 Today Starbucks sees Q2 EPS 45c-50c, consensus 59c 16:06 Today Starbucks reports Q1 EPS 61c, consensus 55c SBUX Starbucks $104.69 / +1.34 (+1.30%) 12/12/20 Starbucks, Disney can still offer investors growth, Barron's says 11/18/20 Starbucks to raise wages for baristas, CNBC reports 10/15/20 Starbucks to tie executive pay to diversity targets, WSJ reports 08/29/20 Starbucks stock getting a post-COVID jolt, Barron's says SBUX Starbucks $104.69 / +1.34 (+1.30%) 12/16/20 Fly Intel: Wall Street's top stories for Wednesday 12/16/20 Fly Intel: Wall Street's top stories at midday 12/10/20 Fly Intel: Wall Street's top stories for Thursday 12/10/20 Fly Intel: Wall Street's top stories at midday 17:00 Today Starbucks - SBUX 03/17/21 Starbucks Corporation SBUX Starbucks $104.69 / +1.34 (+1.30%) 15:19 Today Starbucks options imply 6.1% move in share price post-earnings 12/10/20 Early notable gainers among liquid option names on December 10th 11/17/20 Unusual call flow in option market yesterday 11/16/20 Short-term Starbucks calls see latte early flow
Syndicate	Tiziana Life Sciences files $250M mixed securities shelf 17:33 01/26/21 01/26 17:33 01/26/21 17:33 TLSA Tiziana Life Sciences $3.97 / +0.235 (+6.30%) ShowHide Related Items >><< Company News Street Research Syndicate Options TLSA Tiziana Life Sciences $3.97 / +0.235 (+6.30%) 01/20/21 Tiziana Life Sciences jumps ahead of admission to main market of LSE 01/04/21 Tiziana Life Sciences completes Foralumab study in COVID-19 patients 11/11/20 Tiziana Life Sciences announces collaboration with Parexel on Foralumab trial 11/02/20 Tiziana Life Sciences initiates Foralumab study for COVID-19 patients in Brazil TLSA Tiziana Life Sciences $3.97 / +0.235 (+6.30%) 12/22/20 B. Riley Securities Tiziana Life Sciences initiated with a Buy at B. Riley Securities 12 Mar TLSA Tiziana Life Sciences $3.97 / +0.235 (+6.30%) 08/12/20 Ten new option listings on August 12th
Hot Stocks	Prosperity Bancshares announces up to 4.65M share stock repurchase program » 17:32 01/26/21 01/26 17:32 01/26/21 17:32 PB Prosperity Bancshares $68.47 / -1.26 (-1.81%) Prosperity Bancshares… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Events PB Prosperity Bancshares $68.47 / -1.26 (-1.81%) 01/07/21 BofA Prosperity Bancshares downgraded to Underperform from Neutral at BofA 10/29/20 Raymond James Prosperity Bancshares price target lowered to $65 from $70 at Raymond James 10/29/20 Janney Montgomery Scott Prosperity Bancshares upgraded to Buy from Neutral at Janney Montgomery Scott 07/31/20 Wolfe Research Prosperity Bancshares initiated with a Peer Perform at Wolfe Research PB Prosperity Bancshares $68.47 / -1.26 (-1.81%) 10/28/20 Prosperity Bancshares reports Q3 EPS $1.40, consensus $1.29 07/29/20 Prosperity Bancshares reports Q2 EPS $1.41, consensus $1.15 02/02/21 Texas Bank Virtual Investor Trip 03/11/21 Virtual Atlanta and Texas Bank Summit 01/27/21 Prosperity Bancshares - PB
Hot Stocks	Starbucks COO Roz Brewer to step down » 17:30 01/26/21 01/26 17:30 01/26/21 17:30 SBUX Starbucks $104.69 / +1.34 (+1.30%) In a regulatory 8-K… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SBUX Starbucks $104.69 / +1.34 (+1.30%) 17:20 Today Starbucks says food service continues to be soft 17:19 Today Starbucks entered 15 new cities in China in Q1 17:14 Today Starbucks says mobile orders now make up 25% of all transactions 16:24 Today Starbucks drops 1% to $103.30 after Q2 earnings view misses consensus SBUX Starbucks $104.69 / +1.34 (+1.30%) 01/21/21 MKM Partners Starbucks' Q1 may show slowdown in U.S. comp trends, says MKM Partners 01/19/21 Goldman Sachs Starbucks initiated with a Buy at Goldman Sachs 01/14/21 Cleveland Research Cleveland Research lowers Starbucks Q1 Americas comps forecast 12/16/20 Stephens Starbucks pointed to softer U.S., stronger China than expected, says Stephens SBUX Starbucks $104.69 / +1.34 (+1.30%) 16:59 Today Starbucks backs FY21 revenue view of $28.0B-$29.0B, consensus $28.5B 16:08 Today Starbucks backs FY21 EPS $2.70-$2.90, consensus $2.81 16:07 Today Starbucks sees Q2 EPS 45c-50c, consensus 59c 16:06 Today Starbucks reports Q1 EPS 61c, consensus 55c SBUX Starbucks $104.69 / +1.34 (+1.30%) 12/12/20 Starbucks, Disney can still offer investors growth, Barron's says 11/18/20 Starbucks to raise wages for baristas, CNBC reports 10/15/20 Starbucks to tie executive pay to diversity targets, WSJ reports 08/29/20 Starbucks stock getting a post-COVID jolt, Barron's says SBUX Starbucks $104.69 / +1.34 (+1.30%) 12/16/20 Fly Intel: Wall Street's top stories for Wednesday 12/16/20 Fly Intel: Wall Street's top stories at midday 12/10/20 Fly Intel: Wall Street's top stories for Thursday 12/10/20 Fly Intel: Wall Street's top stories at midday 17:00 Today Starbucks - SBUX 03/17/21 Starbucks Corporation SBUX Starbucks $104.69 / +1.34 (+1.30%) 15:19 Today Starbucks options imply 6.1% move in share price post-earnings 12/10/20 Early notable gainers among liquid option names on December 10th 11/17/20 Unusual call flow in option market yesterday 11/16/20 Short-term Starbucks calls see latte early flow
Hot Stocks	Zions Bancorp VP Blackford sells $187K in shares » 17:28 01/26/21 01/26 17:28 01/26/21 17:28 ZION Zions Bancorp $46.05 / -1.17 (-2.48%) Zions Bancorp VP David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings On The Fly Events Options ZION Zions Bancorp $46.05 / -1.17 (-2.48%) 01/21/21 Argus Zions Bancorp price target raised to $56 from $40 at Argus 01/20/21 Truist Zions Bancorp price target raised to $62 from $50 at Truist 01/20/21 B. Riley Securities Zions Bancorp price target raised to $57 from $55 at B. Riley Securities 01/07/21 B. Riley Securities Zions Bancorp price target raised to $55 from $52 at B. Riley Securities ZION Zions Bancorp $46.05 / -1.17 (-2.48%) 01/19/21 Zions Bancorp reports Q4 EPS $1.66, consensus $1.02 01/19/21 Notable companies reporting after market close 10/19/20 Zions Bancorp reports Q3 EPS $1.01, consensus 88c ZION Zions Bancorp $46.05 / -1.17 (-2.48%) 01/19/21 Fly Intel: After-Hours Movers 10/19/20 Fly Intel: After-Hours Movers 04/19/21 Zions Bancorp - ZION ZION Zions Bancorp $46.05 / -1.17 (-2.48%) 01/19/21 Zions Bancorp options imply 4.3% move in share price post-earnings

Periodicals	Nissan to slash approximately 160 office-based UK jobs, Reuters reports » 17:28 01/26/21 01/26 17:28 01/26/21 17:28 NSANY Nissan $0.00 / + (+0.00%) Nissan will slash about… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly NSANY Nissan $0.00 / + (+0.00%) 01/19/21 EU passenger car registrations down 3.3% in December 01/05/21 Nissan reports Q4 U.S. sales down 19.3% to 243,133 units 12/17/20 EU passenger car registrations down 12.0% in November 11/18/20 AppHarvest appoints Travis Parman as CCO NSANY Nissan $0.00 / + (+0.00%) 12/21/20 SMBC Nikko Nissan upgraded to Neutral from Underperform at SMBC Nikko 10/28/20 Jefferies Nissan upgraded to Hold from Underperform at Jefferies 08/03/20 RBC Capital Renault CEO's H1 results call 'encouraging,' says RBC 07/07/20 Jefferies Nissan downgraded to Underperform from Hold at Jefferies NSANY Nissan $0.00 / + (+0.00%) 01/21/21 Nissan to pause one British production line on January 22, Reuters reports 12/15/20 Mobileye CEO sees building own LIDAR sensors to control costs, Reuters says 12/08/20 Nissan COO says world has reached 'turning point' in electrification, CNBC says 12/04/20 Nissan joins GM in leaving auto group supporting Trump, Reuters says NSANY Nissan $0.00 / + (+0.00%) 12/19/20 Charged: Deutsche sees multiple EV winners, says buy Xpev 12/15/20 Luminar under pressure as Mobileye CEO shares in-house LIDAR plans
Hot Stocks	Point72 Asset Management reports 9.1% passive stake in CytomX Therapeutics » 17:27 01/26/21 01/26 17:27 01/26/21 17:27 CTMX CytomX Therapeutics $6.92 / -0.19 (-2.67%) Point72 Asset Management… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events CTMX CytomX Therapeutics $6.92 / -0.19 (-2.67%) 01/19/21 CytomX Therapeutics announces $75M offering of common stock 01/19/21 CytomX Therapeutics announces employment inducement grants 11/05/20 CytomX Therapeutics treats first patient in Phase 2 expansion study of CX-2029 10/06/20 CytomX Therapeutics announces retirement of CSO Michael Kavanaugh CTMX CytomX Therapeutics $6.92 / -0.19 (-2.67%) 09/22/20 Guggenheim Guggenheim taking more conservative view, downgrades CytomX to Neutral 09/22/20 Guggenheim CytomX Therapeutics downgraded to Neutral from Buy at Guggenheim 09/15/20 Citi CytomX Therapeutics price target lowered to $8.50 from $11 at Citi 06/01/20 Jefferies Jefferies 'underwhelmed' by CytomX presentations at ASCO, downgrades to Hold CTMX CytomX Therapeutics $6.92 / -0.19 (-2.67%) 11/05/20 CytomX Therapeutics reports Q3 EPS (32c), consensus (48c) 21 Jan CTMX CytomX Therapeutics $6.92 / -0.19 (-2.67%) 01/21/21 Fly Intel: Pre-market Movers 01/20/21 Fly Intel: Pre-market Movers 03/01/21 41st Annual Healthcare Virtual Conference
Syndicate	Duck Creek Technologies files to sell 8M shares of common stock » 17:22 01/26/21 01/26 17:22 01/26/21 17:22 DCT Duck Creek Technologies $52.81 / +0.84 (+1.62%) The company is offering… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options DCT Duck Creek Technologies $52.81 / +0.84 (+1.62%) 01/12/21 Builders Mutual Insurance selects Duck Creek Suite OnDemand DCT Duck Creek Technologies $52.81 / +0.84 (+1.62%) 01/13/21 Goldman Sachs Sapiens initiated with a Neutral at Goldman Sachs 10/21/20 RBC Capital Duck Creek Technologies price target raised to $51 from $45 at RBC Capital 10/21/20 Barclays Duck Creek Technologies price target raised to $48 from $43 at Barclays 09/08/20 DA Davidson Duck Creek Technologies initiated with a Buy at DA Davidson DCT Duck Creek Technologies $52.81 / +0.84 (+1.62%) 01/07/21 Duck Creek Technologies sees FY21 revenue $246M-$251M, consensus $246.91M 01/07/21 Duck Creek Technologies sees Q2 revenue $58.5M-$59.5M, consensus $58.73M 01/07/21 Duck Creek Technologies reports Q1 EPS 2c, consensus (1c) 10/20/20 Duck Creek Technologies sees FY21 EPS (4c) -(2c), consensus (10c) 11 Nov 14 Aug DCT Duck Creek Technologies $52.81 / +0.84 (+1.62%) 11/01/20 Opening Day: MediaAlpha jumps 64%, Root falls flat in debut 08/16/20 Opening Day: COVID vaccine researcher surges following IPO 02/11/21 Technology & Internet Virtual Conference DCT Duck Creek Technologies $52.81 / +0.84 (+1.62%) 01/07/21 Duck Creek Technologies options imply 10.1% move in share price post-earnings 09/02/20 Seven new option listings and two option delistings on September 2nd
Hot Stocks	Starbucks says food service continues to be soft » 17:20 01/26/21 01/26 17:20 01/26/21 17:20 SBUX Starbucks $104.69 / +1.34 (+1.30%) Starbucks (SBUX) says… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SBUX Starbucks $104.69 / +1.34 (+1.30%) 17:19 Today Starbucks entered 15 new cities in China in Q1 17:14 Today Starbucks says mobile orders now make up 25% of all transactions 16:24 Today Starbucks drops 1% to $103.30 after Q2 earnings view misses consensus 16:14 Today Starbucks CEO says Q1 started with 'meaningful, sequential improvement' SBUX Starbucks $104.69 / +1.34 (+1.30%) 01/21/21 MKM Partners Starbucks' Q1 may show slowdown in U.S. comp trends, says MKM Partners 01/19/21 Goldman Sachs Starbucks initiated with a Buy at Goldman Sachs 01/14/21 Cleveland Research Cleveland Research lowers Starbucks Q1 Americas comps forecast 12/16/20 Stephens Starbucks pointed to softer U.S., stronger China than expected, says Stephens SBUX Starbucks $104.69 / +1.34 (+1.30%) 16:59 Today Starbucks backs FY21 revenue view of $28.0B-$29.0B, consensus $28.5B 16:08 Today Starbucks backs FY21 EPS $2.70-$2.90, consensus $2.81 16:07 Today Starbucks sees Q2 EPS 45c-50c, consensus 59c 16:06 Today Starbucks reports Q1 EPS 61c, consensus 55c SBUX Starbucks $104.69 / +1.34 (+1.30%) 12/12/20 Starbucks, Disney can still offer investors growth, Barron's says 11/18/20 Starbucks to raise wages for baristas, CNBC reports 10/15/20 Starbucks to tie executive pay to diversity targets, WSJ reports 08/29/20 Starbucks stock getting a post-COVID jolt, Barron's says SBUX Starbucks $104.69 / +1.34 (+1.30%) 12/16/20 Fly Intel: Wall Street's top stories for Wednesday 12/16/20 Fly Intel: Wall Street's top stories at midday 12/10/20 Fly Intel: Wall Street's top stories for Thursday 12/10/20 Fly Intel: Wall Street's top stories at midday 17:00 Today Starbucks - SBUX 03/17/21 Starbucks Corporation SBUX Starbucks $104.69 / +1.34 (+1.30%) 15:19 Today Starbucks options imply 6.1% move in share price post-earnings 12/10/20 Early notable gainers among liquid option names on December 10th 11/17/20 Unusual call flow in option market yesterday 11/16/20 Short-term Starbucks calls see latte early flow
Hot Stocks	Starbucks entered 15 new cities in China in Q1 » 17:19 01/26/21 01/26 17:19 01/26/21 17:19 SBUX Starbucks $104.69 / +1.34 (+1.30%) Says China leadership… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SBUX Starbucks $104.69 / +1.34 (+1.30%) 17:14 Today Starbucks says mobile orders now make up 25% of all transactions 16:24 Today Starbucks drops 1% to $103.30 after Q2 earnings view misses consensus 16:14 Today Starbucks CEO says Q1 started with 'meaningful, sequential improvement' 16:10 Today Starbucks reports Q1 global comps down 5%, Americas comps down 6% SBUX Starbucks $104.69 / +1.34 (+1.30%) 01/21/21 MKM Partners Starbucks' Q1 may show slowdown in U.S. comp trends, says MKM Partners 01/19/21 Goldman Sachs Starbucks initiated with a Buy at Goldman Sachs 01/14/21 Cleveland Research Cleveland Research lowers Starbucks Q1 Americas comps forecast 12/16/20 Stephens Starbucks pointed to softer U.S., stronger China than expected, says Stephens SBUX Starbucks $104.69 / +1.34 (+1.30%) 16:59 Today Starbucks backs FY21 revenue view of $28.0B-$29.0B, consensus $28.5B 16:08 Today Starbucks backs FY21 EPS $2.70-$2.90, consensus $2.81 16:07 Today Starbucks sees Q2 EPS 45c-50c, consensus 59c 16:06 Today Starbucks reports Q1 EPS 61c, consensus 55c SBUX Starbucks $104.69 / +1.34 (+1.30%) 12/12/20 Starbucks, Disney can still offer investors growth, Barron's says 11/18/20 Starbucks to raise wages for baristas, CNBC reports 10/15/20 Starbucks to tie executive pay to diversity targets, WSJ reports 08/29/20 Starbucks stock getting a post-COVID jolt, Barron's says SBUX Starbucks $104.69 / +1.34 (+1.30%) 12/16/20 Fly Intel: Wall Street's top stories for Wednesday 12/16/20 Fly Intel: Wall Street's top stories at midday 12/10/20 Fly Intel: Wall Street's top stories for Thursday 12/10/20 Fly Intel: Wall Street's top stories at midday 17:00 Today Starbucks - SBUX 03/17/21 Starbucks Corporation SBUX Starbucks $104.69 / +1.34 (+1.30%) 15:19 Today Starbucks options imply 6.1% move in share price post-earnings 12/10/20 Early notable gainers among liquid option names on December 10th 11/17/20 Unusual call flow in option market yesterday 11/16/20 Short-term Starbucks calls see latte early flow

Hot Stocks	Washington Federal raises quarterly dividend by 4.5% to 23c per share » 17:16 01/26/21 01/26 17:16 01/26/21 17:16 WAFD Washington Federal $27.85 / -0.54 (-1.90%) The dividend will be paid… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Events Options WAFD Washington Federal $27.85 / -0.54 (-1.90%) 02/19/20 Fly Intel: Top five analyst initiations 02/18/20 Stephens Washington Federal initiated with an Equal Weight at Stephens WAFD Washington Federal $27.85 / -0.54 (-1.90%) 01/14/21 Washington Federal reports Q1 EPS 51c, consensus 42c 10/14/20 Washington Federal reports Q4 EPS 45c, consensus 42c 17:00 Today Washington Federal, Inc. WAFD Washington Federal $27.85 / -0.54 (-1.90%) 01/13/21 Washington Federal options imply 10.7% move in share price post-earnings
Recommendations	Bionano Genomics price target raised to $14 from $1.25 at Ladenburg » 17:15 01/26/21 01/26 17:15 01/26/21 17:15 BNGO Bionano Genomics $12.25 / -0.305 (-2.43%) Ladenburg analyst Jeffrey… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options BNGO Bionano Genomics $12.25 / -0.305 (-2.43%) 08:14 Today Bionano Genomics announces release of Compute On Demand version 1.2 01/25/21 Bionano Genomics Inc trading resumes 01/25/21 Bionano Genomics Inc trading halted, volatility trading pause 01/19/21 Bionano Genomics' Saphyr System shows improved MDS detection in publication BNGO Bionano Genomics $12.25 / -0.305 (-2.43%) 01/22/21 Maxim Bionano Genomics price target raised to $14 from $2 at Maxim 12/04/20 Roth Capital Bionano Genomics downgraded to Neutral from Buy at Roth Capital 12/04/20 Roth Capital Bionano Genomics downgraded to Neutral from Buy at Roth Capital 09/24/20 Ladenburg Bionano Genomics initiated with a Buy at Ladenburg BNGO Bionano Genomics $12.25 / -0.305 (-2.43%) 11/12/20 Bionano Genomics reports Q3 revenue $2.2M, consensus $2.07M. 10/15/20 Bionano Genomics sees Q3 revenue $1.9M-$2.3M, consensus $2.07M 08/13/20 Bionano Genomics reports Q2 net loss ($8.0M) vs. ($7.67M) a year ago 20 Jan 08 Jan BNGO Bionano Genomics $12.25 / -0.305 (-2.43%) 01/19/21 Fly Intel: After-Hours Movers 01/15/21 Fly Intel: Wall Street's top stories at midday 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday BNGO Bionano Genomics $12.25 / -0.305 (-2.43%) 08:45 Today Largest borrow rate increases among liquid names 01/13/21 Thirteen new option listings and two option delistings on January 13th
Earnings	Celestica reports Q4 EPS 26c, consensus 25c » 17:14 01/26/21 01/26 17:14 01/26/21 17:14 CLS Celestica $8.78 / +0.145 (+1.68%) Reports Q4 revenue $1.4B,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events CLS Celestica $8.78 / +0.145 (+1.68%) 12/02/20 Celestica to assess M&A transactions against alternative uses of cash 12/02/20 Celestica on track to generate at least $100M of non-IFRS FCF in 2020 10/28/20 Celestica expects 2020 restructuring costs approx. $30M 09/17/20 Celestica releases 2019 sustainability report CLS Celestica $8.78 / +0.145 (+1.68%) 07/30/20 BMO Capital Celestica price target raised to $8.50 from $7 at BMO Capital 07/30/20 Canaccord Celestica upgraded to Buy from Hold at Canaccord 04/27/20 RBC Capital Celestica price target lowered to $5 from $6 at RBC Capital CLS Celestica $8.78 / +0.145 (+1.68%) 12/02/20 Celestica backs Q4 adj. EPS view 22c-28c, consensus 25c 12/02/20 Celestica reaffirms Q4 revenue, non-IFRS adjusted EPS guidance 10/28/20 Celestica sees Q4 adj. EPS 22c-28c, consensus 22c 10/28/20 Celestica reports Q3 adj. EPS 32c, consensus 25c 01/27/21 Celestica - CLS
Hot Stocks	Starbucks says mobile orders now make up 25% of all transactions » 17:14 01/26/21 01/26 17:14 01/26/21 17:14 SBUX Starbucks $104.69 / +1.34 (+1.30%) Says cold beverages… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SBUX Starbucks $104.69 / +1.34 (+1.30%) 16:24 Today Starbucks drops 1% to $103.30 after Q2 earnings view misses consensus 16:14 Today Starbucks CEO says Q1 started with 'meaningful, sequential improvement' 16:10 Today Starbucks reports Q1 global comps down 5%, Americas comps down 6% 01/07/21 Starbucks backs prior guidance as 'overall business momentum remains positive' SBUX Starbucks $104.69 / +1.34 (+1.30%) 01/21/21 MKM Partners Starbucks' Q1 may show slowdown in U.S. comp trends, says MKM Partners 01/19/21 Goldman Sachs Starbucks initiated with a Buy at Goldman Sachs 01/14/21 Cleveland Research Cleveland Research lowers Starbucks Q1 Americas comps forecast 12/16/20 Stephens Starbucks pointed to softer U.S., stronger China than expected, says Stephens SBUX Starbucks $104.69 / +1.34 (+1.30%) 16:59 Today Starbucks backs FY21 revenue view of $28.0B-$29.0B, consensus $28.5B 16:08 Today Starbucks backs FY21 EPS $2.70-$2.90, consensus $2.81 16:07 Today Starbucks sees Q2 EPS 45c-50c, consensus 59c 16:06 Today Starbucks reports Q1 EPS 61c, consensus 55c SBUX Starbucks $104.69 / +1.34 (+1.30%) 12/12/20 Starbucks, Disney can still offer investors growth, Barron's says 11/18/20 Starbucks to raise wages for baristas, CNBC reports 10/15/20 Starbucks to tie executive pay to diversity targets, WSJ reports 08/29/20 Starbucks stock getting a post-COVID jolt, Barron's says SBUX Starbucks $104.69 / +1.34 (+1.30%) 12/16/20 Fly Intel: Wall Street's top stories for Wednesday 12/16/20 Fly Intel: Wall Street's top stories at midday 12/10/20 Fly Intel: Wall Street's top stories for Thursday 12/10/20 Fly Intel: Wall Street's top stories at midday 17:00 Today Starbucks - SBUX 03/17/21 Starbucks Corporation SBUX Starbucks $104.69 / +1.34 (+1.30%) 15:19 Today Starbucks options imply 6.1% move in share price post-earnings 12/10/20 Early notable gainers among liquid option names on December 10th 11/17/20 Unusual call flow in option market yesterday 11/16/20 Short-term Starbucks calls see latte early flow
Downgrade	ProSight downgraded to Hold from Buy at Truist » 17:12 01/26/21 01/26 17:12 01/26/21 17:12 PROS ProSight $12.61 / + (+0.00%) Truist analyst Mark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals PROS ProSight $12.61 / + (+0.00%) 01/15/21 ProSight falls -9.9% 01/15/21 ProSight falls -9.9% 01/15/21 ProSight falls -9.8% 01/15/21 TowerBrook, Further Global to acquire ProSight for approximately $586M in cash PROS ProSight $12.61 / + (+0.00%) 01/15/21 Keefe Bruyette ProSight downgraded to Market Perform from Outperform at Keefe Bruyette 11/17/20 Barclays ProSight initiated with an Equal Weight at Barclays 05/04/20 SunTrust ProSight price target lowered to $16 from $25 at SunTrust PROS ProSight $12.61 / + (+0.00%) 11/09/20 ProSight reports Q3 adjusted EPS 3c, consensus 18c 08/10/20 ProSight reports Q2 adjusted EPS 39c, consensus 17c PROS ProSight $12.61 / + (+0.00%) 09/24/20 Ritz, Towerbrook teaming up to bid for ProSight, Insurance Insider reports

Syndicate	Calliditas Therapeutics files to sell 4.5M common shares 17:11 01/26/21 01/26 17:11 01/26/21 17:11 CALT Calliditas Therapeutics $31.35 / -0.68 (-2.12%) ShowHide Related Items >><< Company News Street Research Syndicate CALT Calliditas Therapeutics $31.35 / -0.68 (-2.12%) 01/21/21 Calliditas Therapeutics announces full enrollment of NefIgArd trial 01/20/21 Calliditas Therapeutics to provide data from Part A of NefIgArd study 01/18/21 Calliditas says Phase 1 setanaxib trial shows favorable pharmacokinetic profile 11/09/20 Calliditas Therapeutics says Part A of NefIgArd trial met its primary objective CALT Calliditas Therapeutics $31.35 / -0.68 (-2.12%) 07/01/20 Citi Calliditas Therapeutics initiated with a Buy at Citi 06/30/20 Jefferies Calliditas Therapeutics initiated with a Buy at Jefferies 06/30/20 Stifel Calliditas Therapeutics initiated with a Buy at Stifel 05 Jun
Earnings	Select Bancorp reports Q4 EPS 22c, two estimates 13c » 17:05 01/26/21 01/26 17:05 01/26/21 17:05 SLCT Select Bancorp $9.41 / -0.22 (-2.28%) Reports Q4 tangible book… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research SLCT Select Bancorp $9.41 / -0.22 (-2.28%) 10/02/20 Select Bancorp authorizes repurchase of up to 875K outstanding shares SLCT Select Bancorp $9.41 / -0.22 (-2.28%) 08/20/20 DA Davidson Select Bancorp initiated with a Buy at DA Davidson 08/19/20 DA Davidson Select Bancorp initiated with a Buy at DA Davidson
Syndicate	GeoVax Labs files $101.45M mixed securities shelf 17:03 01/26/21 01/26 17:03 01/26/21 17:03 GOVX GeoVax Labs $5.94 / +0.84 (+16.47%) ShowHide Related Items >><< Company News Street Research Syndicate On The Fly GOVX GeoVax Labs $5.94 / +0.84 (+16.47%) 01/11/21 GeoVax Labs awarded NIH grant to advance vaccine development 11/30/20 GeoVax Labs announces license agreement with NIH to support vaccine development 10/26/20 GeoVax Labs announces license agreement with NIH to support vaccine development 10/07/20 GeoVax says design, construction completed on four COVID-19 vaccine candidates GOVX GeoVax Labs $5.94 / +0.84 (+16.47%) 11/19/20 Maxim GeoVax Labs initiated with a Buy at Maxim 11/19/20 Maxim GeoVax Labs initiated with a Buy at Maxim 25 Sep GOVX GeoVax Labs $5.94 / +0.84 (+16.47%) 10/05/20 Fly Insider: Odonate Therapeutics, Carvana among week's notable insider trades
Earnings	Renasant reports Q4 EPS 56c, consensus 59c » 17:03 01/26/21 01/26 17:03 01/26/21 17:03 RNST Renasant $38.43 / +0.12 (+0.31%) Reports Q4 NII $108.1M… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events RNST Renasant $38.43 / +0.12 (+0.31%) 10/27/20 Renasant reports Q3 net interest margin 3.29% vs. 3.98% last year 10/07/20 Renasant to replace Newpark Resources in S&P 600 at open on 10/7 10/01/20 Renasant to replace Newpark Resources in S&P 600 at open on 10/7 07/27/20 Renasant names James Mabry IV as CFO RNST Renasant $38.43 / +0.12 (+0.31%) 09/29/20 Truist Truist raises price targets on select regional banks 09/15/20 Fly Intel: Top analyst downgrades 09/15/20 DA Davidson Renasant downgraded to Neutral from Buy at DA Davidson 03/16/20 DA Davidson Renasant upgraded to Buy from Neutral at DA Davidson RNST Renasant $38.43 / +0.12 (+0.31%) 10/27/20 Renasant reports Q3 EPS 53c, consensus 51c 07/27/20 Renasant reports Q2 EPS 36c, consensus 30c RNST Renasant $38.43 / +0.12 (+0.31%) 10/01/20 Fly Intel: After-Hours Movers 03/11/21 Virtual Atlanta and Texas Bank Summit 01/27/21 Renasant - RNST
Hot Stocks	First Busey raises quarterly dividend nearly 5% to 23c per share » 17:03 01/26/21 01/26 17:03 01/26/21 17:03 BUSE First Busey $22.51 / -0.34 (-1.49%) First Busey will pay a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings BUSE First Busey $22.51 / -0.34 (-1.49%) 01/19/21 First Busey, Cummins-American Corp to merge in $190.8M deal BUSE First Busey $22.51 / -0.34 (-1.49%) 01/07/21 B. Riley Securities First Busey price target raised to $26 from $24 at B. Riley Securities 12/04/20 B. Riley Securities First Busey price target raised to $24 from $20 at B. Riley Securities 04/09/20 Stephens Stephens upgrades Old National, First Busey and S.Y. Bancorp to Overweight 04/09/20 Stephens First Busey upgraded to Overweight from Equal Weight at Stephens BUSE First Busey $22.51 / -0.34 (-1.49%) 17:03 Today First Busey reports Q4 adjusted EPS 62c, consensus 54c 10/27/20 First Busey reports Q3 adjusted EPS 60c, consensus 41c 07/28/20 First Busey reports Q2 EPS 48c, consensus 26c

Events

Earnings calls, analyst events, roadshows and more

J
Today at 18:00

Jacobs Engineering Group Inc. Firm Sponsored Meetings
HRL
Today at 19:00

Hormel Foods Corp. Firm Sponsored Meetings
PLX
Tomorrow at 00:00

PDUFA Date for Pegunigalsidase Alfa Government Event
Tomorrow at 00:00

2021 Virtual Mining Conference Conferences

Virtual Conference
Tomorrow at 00:00

Virtual Global Macro Conference: Asia Pacific 2021 Conferences

Virtual Conference
ESALY ...
Tomorrow at 00:00

Pharmacovigilance & Risk Management Strategies Virtual Conference Conferences

Virtual Conference
CVLT
Tomorrow at 00:00

Commvault Firm Sponsored Meetings

Virtual Meeting
BNED
Tomorrow at 00:00

Barnes & Noble Education Firm Sponsored Meetings

Virtual Meeting
MNPR
Tomorrow at 00:00

Monopar Therapeutics Firm Sponsored Meetings

Virtual Meeting
NBAC
Tomorrow at 00:00

Newborn Acquisition Corp. Firm Sponsored Meetings

Virtual Meeting

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	EZGO X EZGO EZGO Technologies IPO Managers: Priced at: $4.00 2.8M Shares CRKN X CRKN Crown Electrokinetics Secondary Managers: Roth Capital, National Securities, Colliers Priced at: $4.50 4.15M Shares LPCN X LPCN Lipocine Spot Secondary Managers: Raymond James Priced at: $1.75 14.3M Shares SEEL X SEEL Seelos Therapeutics Spot Secondary Managers: BTIG Priced at: $2.05 15.244M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	GRBK X GRBK Green Brick Secondary Managers: Barclays & Goldman Sachs Priced at: $20.95 6M Shares
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	ERF X ERF Enerplus Spot Secondary Managers: RBC Capital & BMO Capital $3.37 28.75M Shares
Tues	SHLS X SHLS Shoals Technologies IPO Managers: Goldman Sachs, JPMorgan, Guggenheim, UBS, Morgan Stanley, Barclays & Credit Suisse, Cowen, Oppenheimer $22.00-23.00 70M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CBIO X CBIO Catalyst Biosciences Spot Secondary Managers: Piper Sandler, Raymond James $5.75-6.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DZSI X DZSI DZS Spot Secondary Managers: Stifel, Needham & B. Riley Securities $14.00 - 14.50 4M Shares PLUG X PLUG Plug Power Spot Secondary Managers: Morgan Stanley $65.00-67.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PSNL X PSNL Personalis Spot Secondary Managers: Morgan Stanley, BofA, Citi & Cowen $38.00 - 40.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial QUMU X QUMU Qumu Spot Secondary Managers: Craig-Hallum $8.10 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	AGFY X AGFY Agrify IPO Managers: Maxim & Roth Capital $8.00-10.00 5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OCDX X OCDX Ortho Clinical IPO Managers: JPMorgan, BofA, Goldman Sachs, Barclays & Morgan Stanley, Citi, Credit Suisse, UBS, Evercore ISI, Piper Sandler, ING Bank, Macquarie, Nomura, TCG Capital Markets, Drexel Hamilton, H.C. Wainwright, Ramirez, Seibert Williams $20.00-23.00 70M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VINP X VINP Vinci Partners Investments IPO Managers: JPMorgan, Goldman Sachs & BTG Pactual, Itau BBA, BofA, Credit Suisse, UBS $16.00-18.00 13.873M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XM X XM Qualtrics IPO Managers: Morgan Stanley & JPMorgan, BofA, Barclays, Deutsche Bank, Goldman Sachs, HSBC, Citi, BMO Capital, Truist, Canaccord, Evercore ISI, JPMorgan, Oppenheimer, Piper Sandler, Raymond James, William Blair, Loop Capital, RMRZ, SEEL $27.00-29.00 50.4M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ZIM X ZIM ZIM Integrated IPO Managers: Citi, Goldman Sachs & Barclays, Jefferies, Clarksons Platou $16.00-19.00 17.5M Shares ASO X ASO Academy Sports Secondary Managers: Credit Suisse, JPMorgan, KKR & BofA $23.69 12M Shares CVAC X CVAC CureVac Secondary Managers: BofA, Jefferies & Evercore ISI, UBS, Guggenheim, Berenberg, Kempen & Co., $104.50 5M Shares SEER X SEER Seer Secondary Managers: JPMorgan, Morgan Stanley, BofA & Cowen $81.35 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SGRY X SGRY Surgery Partners Secondary Managers: JPMorgan & Jefferies, Barclays, KKR, Macquarie $31.30 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SRGA X SRGA Surgalign Secondary Managers: Piper Sandler, Cantor Fitzgerald & BTIG, Craig-Hallum, Lake Street $2.11 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	HMPT X HMPT Home Point Capital IPO Managers: Goldman Sachs, Wells Fargo, Morgan Stanley & UBS, Credit Suisse, JPMorgan, BofA, JMP Securities, Piper Sandler, Seelaus, SPC Capital, Wedbush, Zelman $19.00-21.00 12.5M Shares SEGR X SEGR Southeastern Grocers IPO Managers: BofA & Goldman Sachs, Deutsche Bank, BMO Capital, Truist, Wells Fargo $14.00-16.00 8.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TRIN X TRIN Trinity Capital IPO Managers: Keefe Bruyette, Wells Fargo & UBS, Janney Montgomery Scott, B. Riley Securities, Ladenburg, Compass Point $13.50-15.50 7.55M Shares CALT X CALT Calliditas Therapeutics Secondary Managers: Citi, Jefferies & Stifel, Kempen & Co.,, LifeSci Capital, Carnegie $31.20 4.5M Shares
Fri	No deals

View All Syndicate Announcements »

Hexagon AB price target raised to SEK 640 from SEK 540 at Deutsche Bank

TODAY'S FREE FLY STORIES

Get Full Fly Access